Common Contracts

EX-10.9 11 d445089dex109.htm EX-10.9 Execution Copy 03/28/2008 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY OF PENNSYLVANIA Amended and...

Patent License Agreement • May 5th, 2020 • Pennsylvania

• Contract Type
  Patent License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Pennsylvania

This Amended and Restated Patent License Agreement (this “Agreement”) , effective March 28, 2008 (the “Restatement Date”) is by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Potentia Pharmaceuticals Inc., a Delaware corporation (“Company”), and is an amendment to and restatement of the original Patent License Agreement (the “Original Agreement”) which became effective on August 1, 2006 (the “Original Agreement Effective Date”).

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY OF PENNSYLVANIA Amended and Restated Patent License Agreement

Patent License Agreement • October 13th, 2017 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Pennsylvania

• Contract Type
  Patent License Agreement
• Filed
  October 13th, 2017
• Company
  Apellis Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Pennsylvania

THIS THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”) is entered into as of March , 2008, by and among Potentia Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and those individuals identified on Exhibit A hereto (individually, each a “Stockholder” and collectively, the “Stockholders”).